The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.
The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.
复制标题
DOI:
10.1016/j.addr.2021.114082
复制
发表时间:
2022-03
影响因子:
16.1
通讯作者:
King PH
中科院分区:
文献类型:
--
作者:
Guha A;Waris S;Nabors LB;Filippova N;Gorospe M;Kwan T;King PH
Glioblastoma (GBM) is a malignant and aggressive brain tumor with a median survival of ~ 15 months. Resistance to treatment arises from the extensive cellular and molecular heterogeneity in the three major components: glioma tumor cells, glioma stem cells, and tumor-associated microglia and macrophages. Within this triad, there is a complex network of intrinsic and secreted factors that promote classic hallmarks of cancer, including angiogenesis, resisting cell death, proliferation, and immune evasion. A regulatory node connecting these diverse pathways is at the posttranscriptional level as mRNAs encoding many of the key drivers contain adenine- and uridine rich elements (ARE) in the 3’ untranslated region. Human antigen R (HuR) binds to ARE-bearing mRNAs and is a major positive regulator at this level. This review focuses on basic concepts of ARE-mediated RNA regulation and how targeting HuR with small molecule inhibitors represents a plausible strategy for a multi-pronged therapeutic attack on GBM.
登录
查看更多内容
影响因子:
14.9
作者:
Bakheet T;Williams BR;Khabar KS
通讯作者:
Khabar KS
DOI:
10.1016/j.bbagrm.2013.02.003
发表时间:
2013-06
影响因子:
4.7
作者:
Brooks, Seth A.;Blackshear, Perry J.
通讯作者:
Blackshear, Perry J.
影响因子:
7.3
作者:
Chen Z;Hambardzumyan D
通讯作者:
Hambardzumyan D
DOI:
10.1016/j.bbrc.2006.05.093
发表时间:
2006-07-21
影响因子:
3.1
作者:
Chen, Yu-Ling;Huang, Ya-Lin;Chang, Ching-Jin
通讯作者:
Chang, Ching-Jin
影响因子:
14.2
作者:
Casolaro, Vincenzo;Fang, Xi;Stellato, Cristiana
通讯作者:
Stellato, Cristiana